A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece

Απλή σελίδα τεκμηρίου
dc.contributor.authorPliaka, V.en
dc.contributor.authorRuether, I. G.en
dc.contributor.authorKyriakopoulou, Z.en
dc.contributor.authorKioussi, P.en
dc.contributor.authorPlakokefalos, E.en
dc.contributor.authorMegalou, M.en
dc.contributor.authorPratti, A.en
dc.contributor.authorLevidiotou-Stefanou, S.en
dc.contributor.authorMarkoulatos, P.en
dc.date.accessioned2015-11-24T19:39:07Z
dc.date.available2015-11-24T19:39:07Z
dc.identifier.issn1469-0691-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/24215
dc.rightsDefault Licence-
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAntibodies, Viral/*blooden
dc.subjectChilden
dc.subjectChild, Preschoolen
dc.subjectGreece/epidemiologyen
dc.subjectHumansen
dc.subjectImmunization Scheduleen
dc.subjectImmunization, Secondaryen
dc.subjectInfanten
dc.subjectNeutralization Testsen
dc.subjectPoliomyelitis/epidemiology/immunology/prevention & controlen
dc.subjectPoliovirus/*immunologyen
dc.subjectPoliovirus Vaccine, Oral/administration & dosage/*immunologyen
dc.subjectPoliovirus Vaccines/administration & dosage/*immunologyen
dc.subjectSeroepidemiologic Studiesen
dc.subjectVaccinationen
dc.subjectVaccines, Attenuated/administration & dosage/*immunologyen
dc.subjectVaccines, Synthetic/administration & dosage/immunologyen
dc.titleA seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greeceen
heal.abstractIn this study, the serological status of the southern Greek population in the 1-10-year, 11-20-year, 21-30-year and 31-40-year age groups with regard to Sabin vaccine strains and a collection of 15 recombinant and four non-recombinant poliovirus vaccine strains was determined. For all three poliovirus types, the highest neutralization test (NT) titres were observed in the 1-10- year age group, indicating a good response to vaccination. In general, the serological status of the population of southern Greece with regard to poliovirus is better for types 1 and 2 than for type 3. The presence of the lowest NT titre in the 21- 30-year age group against poliovirus type 3 suggests the need for a booster dose of monovalent Sabin3 vaccine to ensure personal and herd immunity.en
heal.accesscampus-
heal.fullTextAvailabilityTRUE-
heal.identifier.primary10.1111/j.1469-0691.2010.03188.x-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/20148919-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1469-0691.2010.03188.x/asset/j.1469-0691.2010.03188.x.pdf?v=1&t=h0aiov6f&s=552e94b7876dad61c0798e6e6e7d2ab5458de689-
heal.journalNameClin Microbiol Infecten
heal.journalTypepeer-reviewed-
heal.languageen-
heal.publicationDate2010-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.typejournalArticle-
heal.type.elΆρθρο Περιοδικούel
heal.type.enJournal articleen

Αρχεία

Φάκελος/Πακέτο αδειών

Προβολή: 1 - 1 of 1
Μικρογραφία εικόνας
Ονομα:
license.txt
Μέγεθος:
1.74 KB
Μορφότυπο:
Item-specific license agreed upon to submission
Περιγραφή:
Κατεβάστε

Συλλογές

Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ